West Pharmaceutical Services, Inc. (NYSE:WST) Receives $332.50 Consensus Target Price from Analysts
Shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) have received an average rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy […]
Shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) have received an average rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy […]
